
Haemonetics (HAE)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Haemonetics (HAE) Stock
Start investing in Haemonetics (HAE)
About Haemonetics (HAE)
Market cap | $3.37B |
Today's volume | 289.02K |
Revenue (TTM) | $1.36B |
Avg. daily volume | 630.94K |
EBITDA (TTM) | $330.46M |
Open | $70.45 |
Price / earnings ratio | 21.13x |
Today's range | $69.77 - $70.97 |
Debt / equity | 156.35x |
52 week range | $55.3 - $94.99 |
5 year debt / equity | 96.95x |
Beta (LTM) | 0.64x |
Interest coverage | 22.49x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 1.62x |
Ex-dividend date | — |
Next earnings | Aug 7, 2025 |
Dividend payable date | — |
Haemonetics Stock Rating
Haemonetics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy HAE stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in HAE stock
Navigate to the Explore page. Then, type HAE into the search bar. When you see HAE stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased HAE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Haemonetics Stock Earnings
The value each HAE share was expected to gain vs. the value that each HAE share actually gained.
Haemonetics (HAE) reported Q4 2025 earnings per share (EPS) of $1.24, beating estimates of $1.22 by 1.64%. In the same quarter last year, Haemonetics's earnings per share (EPS) was $0.90. Haemonetics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.